Teriparatide biosimilar (Intas Pharmaceuticals)
特立帕肽生物类似药（Intas Pharmaceuticals）
Report date: 2022/08/01 10:56:10
Base Information
Drug NameTeriparatide biosimilar (Intas Pharmaceuticals)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2010/12/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIntas Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesIntas BiopharmaceuticalsAccord Healthcare Slu
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A